Re: Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
- PMID: 32820999
- DOI: 10.1097/JU.0000000000001258.01
Re: Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
Comment on
-
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1007-1014. doi: 10.2215/CJN.13861119. Epub 2020 Jun 11. Clin J Am Soc Nephrol. 2020. PMID: 32527945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources